|
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Aptitude Software Group PLC - London-based finance software firm - Says it made ‘solid strategic and operation progress’ in 2025 with ‘a number of notable wins and expansions across its software portfolio’. The firm expects to report profit in line with expectations and an improving operating margin on-year. Revenue for the year is around £65 million, down 7.1% from £70 million in 2024. ‘This is a reflection of new wins, successful go-lives, and the planned transition of services delivery to partners as well as the impact of timing-related deal deferrals driven by increased macro-economic uncertainty,’ the firm says. On a constant currency basis, overall annual recurring revenue falls 1.0% to £49.8 million from £50.3 million. Gross ARR rises by around 10% during the year but is offset by expected churn in legacy products. Aptitude Software expects legacy products churn to reduce in 2026. ‘The sales pipeline strengthened significantly during the period, with the overall pipeline value growing approximately 65% year-on-year and the later-stage pipeline expanding further, providing improved visibility into [financial 2026],’ it says. The company adds that it is ‘encouraged’ by the underlying quality of the pipeline. ‘While macro-economic uncertainty in certain regions continues to influence deal timing, the board remains confident in the group’s strategic direction,’ Aptitude Software says. The firm expects to report full year results for 2025 on April 8. ---------- Gaming Realms PLC - London-based mobile betting games developer - Expects to report revenue of £31.4 million for 2025, up 10% on-year. It sees adjusted earnings before interest, tax, depreciation and amortisation of £15.0 million, 15% higher than a year prior. Exchange fluctuations during the year had a negative impact of £600,000 on revenue and £400,000 on adjusted Ebitda. ‘The strong performance was driven primarily by content and brand licensing, supported by strong growth across the majority of our major markets,’ Gaming Realms says. The firm notes that revenue in the UK fell 10% during the year, as a result of the introduction of staking limits in the UK on April 1, 2025. However, it notes that UK revenue recovered to previous levels by the end of 2025, supported by the roll-out of a new Slingo in-game tool designed for the UK regulatory environment. The firm says early trading in 2026 has been ‘encouraging’ with ‘ongoing demand’ for the Slingo portfolio. ‘The company remains focused on continued product innovation to drive future growth, supported by increased investment in game development, new products and new market launches,’ it says. ‘We are pleased to report another record year for Gaming Realms, reflecting the continued appeal of the Slingo portfolio and our highly scalable licensing model. We are encouraged by the continued momentum in the US, where regulated iGaming continues to grow strongly, and we see significant additional growth opportunities in US markets,’ says Chief Executive Mark Segal. ‘With increased investment in our games pipeline, the development of new products, and continued expansion into newly regulated territories such as South Africa and Switzerland, alongside forthcoming opportunities in Alberta and Maine, we look forward to building on this momentum in 2026 as we broaden our market reach and further strengthen our portfolio of innovative content.’ ---------- Sanderson Design Group PLC - London-based interior design and furnishings group - Shares jump 15% as the firm says it traded in line with management expectations for the financial year to the end of January. It expects financial 2026 revenue of £99.5 million, down 0.9% from £100.4 million a year ago in reported currency, and consistent with the prior year in constant currency. The firm expects adjusted underlying profit of at least £5 million, up from £4.4 million. ‘This strong growth in profitability reflects the board’s continued focus on strategic cost-saving initiatives,’ Sanderson says. Net cash builds in the second half of the year to £9.8 million at the end of January from £7.8 million six months earlier. The firm notes strong growth in brand sales in the US and other overseas markets in the second half of the year. ‘Licensing performed robustly throughout the year and, within brand sales, the direct-to-consumer channel achieved rapid growth, primarily reflecting Morris & Co sales,’ Sanderson adds. It says trading conditions continued to be subdued in the second half in the UK. Looking ahead, the company says: ‘As we begin the new financial year, there is increasing momentum in the business, particularly in the US, manufacturing and [direct-to-consumer], although UK trading conditions remain subdued.’ ---------- One Health Group PLC - Yorkshire, England-based independent provider of elective surgical care - Confirms that trading in the second half of the year ‘remains strong’ and it is on track to deliver growth in revenue and underlying earnings before interest, tax, depreciation and amortisation for the financial year to the end of March. It sees revenue and underlying Ebitda in line with market expectations. The firm takes the market range for revenue as between £29.2 million and £29.6 million, with underlying Ebitda of £2.3 million. One Health says it expects revenue at the higher end of the consensus range. ‘[Financial 2026] trading will show continued growth across all operation and financial key performance indicators,’ One Health says. The company receives guidance that the final pre-commencement planning condition sign-off for its new-build surgical hub will be confirmed in the coming weeks. On completion, it expects the new hub to provide significant additional capacity and ‘has the potential to materially enhance the group’s revenue and profitability’. ‘We are delighted that our growth plans remain unaffected by wider concerns of reductions in elective surgery across England,’ says Chief Executive Officer Adam Binns. ---------- capAI PLC - focused on artificial intelligence systems for media and medicine - Reports a conditional £252,500 fundraise at 1.0p per share to support development and early-stage commercialisation across its capMedical and capMedia platforms. The company says the placing and subscription include £40,000 of director participation, with proceeds earmarked for platform development, partnership structuring and working capital. capAI says capMedical is developing tiered longevity and preventative health programmes priced between $500 and $15,000 per user, subject to ongoing licensing discussions, while capMedia expands its publishing pipeline via the Author42 platform, which is generating initial revenue. The company says it continues to operate a capital-light model, with no obligation to complete platform acquisitions, maintaining strategic flexibility as it assesses scalable, margin-accretive opportunities across its verticals. Executive Chair Ronjon Nag says: ‘Our initial focus within capMedical reflects demand for preventative and longevity-oriented healthcare solutions, while our progress across capMedia highlights how shared platforms and scalable intellectual property can support multiple, complementary routes to value over time. I am particularly enthused by our inaugural concept within capMedical. While there is a broad range of products already available in the market, we believe our potential competitive edge lies in offering a more comprehensive and consolidated approach to ageing, spanning brain, metabolic, cardiovascular, skin and facial, and immune system health, relative to solutions that are either more fragmented or consolidated but less comprehensive in scope.’ ---------- GenIP PLC - London-based generative AI services provider - Reports ‘continued momentum’ across corporate and academic markets. The firm says an unnamed UK university has expanded the use of its products beyond the Invention Evaluator report, by commissioning ‘analysis to support decisions across their technology portfolio’. It says discussions and proposals continue with academic institutes in Europe, Latin America and the Middle East. ‘This update reflects a clear evolution in how organisations are engaging with GenIP. Repeat customers are expanding their use of our products, while new corporate clients are adopting higher-value, portfolio-level solutions as part of their ongoing decision-making processes,’ says Chief Executive Officer Melissa Cruz. ---------- Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
